Katherine Arndtz, Gideon M. Hirschfield – 9 January 2018

Hongping Zheng, Yotsawat Pomyen, Maria Olga Hernandez, Caiyi Li, Ferenc Livak, Wei Tang, Hien Dang, Tim F. Greten, Jeremy L. Davis, Yongmei Zhao, Monika Mehta, Yelena Levin, Jyoti Shetty, Bao Tran, Anuradha Budhu, Xin Wei Wang – 9 January 2018 – Intratumor molecular heterogeneity of hepatocellular carcinoma is partly attributed to the presence of hepatic cancer stem cells (CSCs). Different CSC populations defined by various cell surface markers may contain different oncogenic drivers, posing a challenge in defining molecularly targeted therapeutics.

Andrew Wey, Joshua Pyke, David P. Schladt, Sommer E. Gentry, Tim Weaver, Nicholas Salkowski, Bertram L. Kasiske, Ajay K. Israni, Jon J. Snyder – 9 January 2018 – Offer acceptance practices may cause geographic variability in allocation Model for End‐Stage Liver Disease (aMELD) score at transplant and could magnify the effect of donor supply and demand on aMELD variability.

Jacqueline G. O'Leary, K. Rajender Reddy, Guadalupe Garcia‐Tsao, Scott W. Biggins, Florence Wong, Michael B. Fallon, Ram M. Subramanian, Patrick S. Kamath, Paul Thuluvath, Hugo E. Vargas, Benedict Maliakkal, Puneeta Tandon, Jennifer Lai, Leroy R. Thacker, Jasmohan S. Bajaj – 8 January 2018 – The North American Consortium for the Study of End‐Stage Liver Disease's definition of acute‐on‐chronic liver failure (NACSELD‐ACLF) as two or more extrahepatic organ failures has been proposed as a simple bedside tool to assess the risk of mortality in hospitalized patients with cirrhosis.

Kavish R. Patidar, Le Kang, Jasmohan S. Bajaj, Daniel Carl, Arun J. Sanyal – 8 January 2018 – Current approaches to determine the cause of acute kidney injury (AKI) in patients with cirrhosis are suboptimal. The aim of this study was to determine the utility of fractional excretion of urea (FEUrea) for the differential diagnosis of AKI in patients with cirrhosis. A retrospective analysis was performed in patients (n = 50) with cirrhosis and ascites admitted with AKI.

Leonard Knegendorf, Svenja A. Drave, Viet Loan Dao Thi, Yannick Debing, Richard J. P. Brown, Florian W. R. Vondran, Kathrin Resner, Martina Friesland, Tanvi Khera, Michael Engelmann, Birgit Bremer, Heiner Wedemeyer, Patrick Behrendt, Johan Neyts, Thomas Pietschmann, Daniel Todt, Eike Steinmann – 8 January 2018 – Hepatitis E virus (HEV) is a member of the genus Orthohepevirus in the family Hepeviridae and the causative agent of hepatitis E in humans. HEV is a major health problem in developing countries, causing mortality rates up to 25% in pregnant women.

Sanchuan Lai, Yasuko Iwakiri – 8 January 2018

Leonard Knegendorf, Svenja A. Drave, Viet Loan Dao Thi, Yannick Debing, Richard J. P. Brown, Florian W. R. Vondran, Kathrin Resner, Martina Friesland, Tanvi Khera, Michael Engelmann, Birgit Bremer, Heiner Wedemeyer, Patrick Behrendt, Johan Neyts, Thomas Pietschmann, Daniel Todt, Eike Steinmann – 8 January 2018 – Hepatitis E virus (HEV) is a member of the genus Orthohepevirus in the family Hepeviridae and the causative agent of hepatitis E in humans. HEV is a major health problem in developing countries, causing mortality rates up to 25% in pregnant women.

Qiang Liu, Ahmed Nassar, Laura Buccini, Patrick Grady, Basem Soliman, Ahmed Hassan, Daniele Pezzati, Giuseppe Iuppa, Teresa Diago Uso, Charles Miller, Cristiano Quintini – 6 January 2018

Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi – 6 January 2018 – The gut microbiome outnumbers the human genome by 150‐fold and plays important roles in metabolism, immune system education, tolerance development, and prevention of pathogen colonization. Dysbiosis has been associated with nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and alcoholic liver disease (ALD) as well as cirrhosis and complications. This article provides an overview of this relationship. Liver Transplantation 24 539–550 2018 AASLD.